Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Puerto Rico Pharmaceuticals and Healthcare Report Q3 2008

Published by: Business Monitor International

Published: Sep. 17, 2008 - 54 Pages


Table of Contents


Executive Summary
Puerto Rico Pharmaceuticals And Healthcare Industry SW6
Business Environment Rating
Puerto Rico - Business Environment Rating
Table: Americas Pharmaceutical Business Environment Ratings
Limits To Potential Returns
Puerto Rico - Market Summary
Regulatory Regime
Pricing And Reimbursement Issues
Tax Incentives
Table: Puerto Rico - Incentives, Benefits And Discounts For Pharmaceutical Manufacturers
Trade Accords
Industry Developments
Biotechnology
Company Activity
Industry Forecast Scenario
Overall Market Forecast
Table: Drug Market Forecasts
Macroeconomic Forecast
Table: Puerto Rico: Historical Data And Forecasts
Patented Market Forecast
Table: Prescription Market Forecast12 (US$mn unless otherwise stated)
Table: OTC Market Forecast12 (US$mn unless otherwise stated)
Generics Market Forecast
Table: Generics Market Forecast12
Medical Device Market Forecast
Table: Puerto Rico Medical Device Market Forecast
Export/Import Forecasts
Table: Puerto Rico’s Pharmaceuticals Exports And Import12 (US$mn)
Key Risks To BMI’s Forecast Scenario
Competitive Landscape
Overview
Table: Pharmaceutical Sales In Puerto Rico (US$mn), Augu, MAT
.Company Monitor
Eli Lilly
Abbott Laboratories
Pfizer
GlaxoSmithKline
Merck & Co
Regional Overview - Central America And Caribbean, DR-CAFTA Region
BMI Forecast Modelling
How We Generate Our Pharmaceutical Industry Forecasts
Pharmaceutical Industry
Pharmaceutical Business Environment Ratings Methodology
Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Weighting
Table: Weighting Of Components
Sources

Abstract

Puerto Rico’s ongoing economic problems will impact the pharmaceutical market over the forecast period.According, to BMI’s drug sector calculations, based on our new industry modelling system, the totalmarket will reach a value of US$4,139.3mn by 2012, up from US$2,647mn in 2007. In 2008, the nominalgrowth rate of the market will be 9.9%. However, in real terms, growth will be in negative territory,showing the inflationary pressure bearing on the market.

In terms of company activity, the latest quarter has been quiet. One interesting move has been the return ofIsraeli generics firm Teva to manufacturing on the Island, after purchasing an API plant from Germany’sArchimica. On a less positive note, Canadian drugmaker Biovail is to close two of its manufacturing plantsin Puerto Rico, as it seeks to restructure following disappointing financial results. Production will transferto the company's existing facility in Steinbach, Manitoba. The closures are expected to take between18months to two years and are intended to reduce infrastructure expenditure and increase available capital.

Although the traditional pharmaceutical manufacturing sector is struggling in Puerto Rico, BMI believesthat the country has the potential to develop a thriving industry, by producing biologics. Indeed, as a UScommonwealth, Puerto Rico operates under US law for intellectual property, currency, banking andcustoms. Yet, companies do not have to pay Federal taxes. The local rate of corporation tax is 7%. What ismore, technological expertise should give the island an advantage over rival low-tax havens in the region.Meanwhile, after updating our market forecasts, Puerto Rico has jumped to third-place in our BusinessEnvironment Rankings for the Americas region. Puerto Rico’s high per-capita spend on drugs, which is ona par with developed nations such as the US and Canada, as well as its world leading intellectual propertyaccords, ensures that the island remains a high-potential investment location.

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options

Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008